jpg.jpg
Incysus Therapeutics to Participate in Evercore ISI HealthCONx Conference
November 26, 2019 07:00 ET | Incysus Therapeutics, Inc.
NEW YORK, Nov. 26, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
LogoPressRelease.jpg
Fluidigm to Participate in the 31st Annual Piper Jaffray Healthcare Conference
November 13, 2019 16:05 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
jpg.jpg
Incysus Therapeutics to Present at the New York Oncology Investor Conference
November 07, 2019 07:00 ET | Incysus Therapeutics, Inc.
NEW YORK, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
Immunicum AB (publ)
Immunicum AB (publ) Interim Report January – September 2019
November 06, 2019 02:00 ET | Immunicum AB
Press Release 6 November 2019 Immunicum AB (publ) Interim Report January – September 2019 Important milestone passed with MERECA topline results SIGNIFICANT EVENTS DURING JULY - SEPTEMBER ...
Immunicum AB (publ)
Immunicum AB (publ) Delårsrapport Januari – september 2019
November 06, 2019 02:00 ET | Immunicum AB
Pressmeddelande 6 november 2019 Immunicum AB (publ) Delårsrapport Januari – september 2019 Topline-resultaten för MERECA-studien - en viktig milstolpe för Immunicum JULI – SEPT I...
LogoPressRelease.jpg
Fluidigm Announces Third Quarter 2019 Financial Results
November 05, 2019 16:05 ET | Fluidigm Corporation
Third quarter revenue decreased 8.5 percent to $26.5 million; year-to-date revenue increased 5 percent to $84.8 million Third quarter consumables revenue increased 11 percent Year-to-date mass...
Cytek Amsterdam Office
Cytek Biosciences Expands Global Reach
October 30, 2019 10:05 ET | Cytek Biosciences
FREMONT, Calif., Oct. 30, 2019 (GLOBE NEWSWIRE) -- Cytek Biosciences Inc.'s mission to make full spectrum flow cytometry accessible to a larger number of scientists continues to resonate with the...
provectus_logo.jpg
Provectus Announces Acceptance of PV-10® Poster Presentations at ESMO Immuno-Oncology Congress 2019
October 24, 2019 07:00 ET | Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that data from an ongoing clinical trial of lysosomal-targeting, cancer immunotherapy PV-10 (rose bengal...
Innate Pharma Announces Closing of Global Offering
October 21, 2019 16:11 ET | INNATE PHARMA
INNATE PHARMA S.A. (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate Pharma” or the “Company”), a French biotechnology company focused on discovering, developing and commercializing...
Immunicum AB (publ)
Immunicum AB (publ) meddelar positiva prekliniska resultat för Ilixadencel i kombination med checkpointhämmaren CTLA-4
October 21, 2019 04:30 ET | Immunicum AB
Pressmeddelande 21 oktober 2019 Immunicum AB (publ) meddelar positiva prekliniska resultat för Ilixadencel i kombination med checkpointhämmaren CTLA-4 Immunicum AB (publ) meddelade i dag...